Skip to main content
Erschienen in: Supportive Care in Cancer 12/2015

01.12.2015 | Original Article

Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jaw

verfasst von: Paula Baptistella de Lima, Veruska Lima Moura Brasil, Jurema Freire Lisboa de Castro, Flávia Maria de Moraes Ramos-Perez, Fábio Abreu Alves, Maria Luiza dos Anjos Pontual, Danyel Elias da Cruz Perez

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to evaluate the knowledge of Brazilian dentists (DEN) and dental students (DS) about bisphosphonates (BP) and bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Methods

A convenience sample of 104 DEN and 100 DS was randomly selected and invited to answer a questionnaire. The questionnaire was structured on the basis of the main information about BP and the risk factors associated with the development of BRONJ. The data obtained were analyzed by the chi-square and Fisher’s exact tests, considering significance of 5 %.

Results

Seventy-five (72.1 %) DEN and 75 (75 %) DS did not know the BP cited in the questionnaire (p < 0.0001), and their commercial brand names were not recognized by 88 (84.6 %) DEN and 86 (86 %) DS (p < 0.0001). In the same way, 62 (59.6 %) DEN (p = 0.04) and 58 (58 %) DS (p < 0.0001) did not recognize BRONJ as an oral side effect of BP or point out oral conditions that were not associated with the use of BP.

Conclusions

Practical initiatives, such as free lectures and workshops, must be taken to broaden the knowledge of DEN and DS about BP and thus contribute to the prevention of BRONJ.
Literatur
2.
Zurück zum Zitat Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS (2009) Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 121:475–483CrossRef Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS (2009) Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 121:475–483CrossRef
3.
Zurück zum Zitat Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg 67:2–12CrossRefPubMed Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg 67:2–12CrossRefPubMed
4.
Zurück zum Zitat Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F, American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938–1956CrossRefPubMed Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F, American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938–1956CrossRefPubMed
5.
Zurück zum Zitat Pires FR, Miranda A, Cardoso ES, Cardoso AS, Fregnani ER, Pereira CM, Correa ME, Almeida JP, Alves Fde A, Lopes MA, de Almeida OP (2005) Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy. Oral Dis 11:365–369CrossRefPubMed Pires FR, Miranda A, Cardoso ES, Cardoso AS, Fregnani ER, Pereira CM, Correa ME, Almeida JP, Alves Fde A, Lopes MA, de Almeida OP (2005) Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy. Oral Dis 11:365–369CrossRefPubMed
6.
Zurück zum Zitat Mercer E, Norton T, Woo S, Treister N, Dodson TB, Solomon DH (2013) Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series. Calcif Tissue Int 93:241–248PubMedCentralCrossRefPubMed Mercer E, Norton T, Woo S, Treister N, Dodson TB, Solomon DH (2013) Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series. Calcif Tissue Int 93:241–248PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum S, Pautke C (2012) Bisphosphonate-related osteonecrosis of the jaws—characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 40:303–309CrossRefPubMed Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum S, Pautke C (2012) Bisphosphonate-related osteonecrosis of the jaws—characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 40:303–309CrossRefPubMed
8.
Zurück zum Zitat Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N (2009) Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg 67:850–855CrossRefPubMed Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N (2009) Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg 67:850–855CrossRefPubMed
9.
Zurück zum Zitat Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA (2011) Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:195–202CrossRefPubMed Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA (2011) Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:195–202CrossRefPubMed
10.
Zurück zum Zitat Hallmer F, Bjørnland T, Nicklasson A, Becktor JP, Andersson G (2014) Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden. Oral Surg Oral Med Oral Pathol Oral Radiol 118:202–208CrossRefPubMed Hallmer F, Bjørnland T, Nicklasson A, Becktor JP, Andersson G (2014) Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden. Oral Surg Oral Med Oral Pathol Oral Radiol 118:202–208CrossRefPubMed
11.
Zurück zum Zitat Vandone AM, Donadio M, Mozzati M, Ardine M, Polimeni MA, Beatrice S, Ciuffreda L, Scoletta M (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol 23:193–200CrossRefPubMed Vandone AM, Donadio M, Mozzati M, Ardine M, Polimeni MA, Beatrice S, Ciuffreda L, Scoletta M (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol 23:193–200CrossRefPubMed
12.
Zurück zum Zitat López-Jornet P, Camacho-Alonso F, Molina-Miñano F, Gomez-Garcia F (2010) Bisphosphonate-associated osteonecrosis of the jaw. Knowledge and attitudes of dentists and dental students: a preliminary study. J Eval Clin Pract 16:878–882CrossRefPubMed López-Jornet P, Camacho-Alonso F, Molina-Miñano F, Gomez-Garcia F (2010) Bisphosphonate-associated osteonecrosis of the jaw. Knowledge and attitudes of dentists and dental students: a preliminary study. J Eval Clin Pract 16:878–882CrossRefPubMed
13.
Zurück zum Zitat Abu-id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T (2008) “Bis-phossy jaws”—high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 36:95–103CrossRefPubMed Abu-id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T (2008) “Bis-phossy jaws”—high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 36:95–103CrossRefPubMed
14.
Zurück zum Zitat Bauer JS, Beck N, Kiefer J, Stockmann P, Wichmann M, Eitner S (2012) Awareness and education of patients receiving bisphosphonates. J Craniomaxillofac Surg 40:277–282CrossRefPubMed Bauer JS, Beck N, Kiefer J, Stockmann P, Wichmann M, Eitner S (2012) Awareness and education of patients receiving bisphosphonates. J Craniomaxillofac Surg 40:277–282CrossRefPubMed
15.
Zurück zum Zitat Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM, Castronovo V, Green JR (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302:1055–1061CrossRefPubMed Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM, Castronovo V, Green JR (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302:1055–1061CrossRefPubMed
16.
Zurück zum Zitat de Souza Faloni AP, Queiroz TP, Comelli Lia RC, Cerri PS, Margonar R, Rastelli AN, Marcantonio E (2011) Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 22:2185–2190CrossRefPubMed de Souza Faloni AP, Queiroz TP, Comelli Lia RC, Cerri PS, Margonar R, Rastelli AN, Marcantonio E (2011) Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 22:2185–2190CrossRefPubMed
17.
Zurück zum Zitat Migliorati CA, Mattos K, Palazzolo MJ (2010) How patients’ lack of knowledge about oral bisphosphonates can interfere with medical and dental care. J Am Dent Assoc 141:562–566CrossRefPubMed Migliorati CA, Mattos K, Palazzolo MJ (2010) How patients’ lack of knowledge about oral bisphosphonates can interfere with medical and dental care. J Am Dent Assoc 141:562–566CrossRefPubMed
18.
Zurück zum Zitat Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carrière P, Dansey R (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341–1347CrossRefPubMed Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carrière P, Dansey R (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341–1347CrossRefPubMed
19.
Zurück zum Zitat Dhima M, Petropoulos VC, Han RK, Kinnunen T, Wright RF (2012) Dental students' perceptions of dental specialties and factors influencing specialty and career choices. J Dent Educ 76:562–573PubMed Dhima M, Petropoulos VC, Han RK, Kinnunen T, Wright RF (2012) Dental students' perceptions of dental specialties and factors influencing specialty and career choices. J Dent Educ 76:562–573PubMed
20.
Zurück zum Zitat Epstein JB, Kish RV, Hallajian L, Sciubba J (2015) Head and neck, oral and oropharyngeal cancer: a review of medicolegal cases. Oral Surg Oral Med Oral Pathol Oral Radiol 119:177–186CrossRefPubMed Epstein JB, Kish RV, Hallajian L, Sciubba J (2015) Head and neck, oral and oropharyngeal cancer: a review of medicolegal cases. Oral Surg Oral Med Oral Pathol Oral Radiol 119:177–186CrossRefPubMed
Metadaten
Titel
Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jaw
verfasst von
Paula Baptistella de Lima
Veruska Lima Moura Brasil
Jurema Freire Lisboa de Castro
Flávia Maria de Moraes Ramos-Perez
Fábio Abreu Alves
Maria Luiza dos Anjos Pontual
Danyel Elias da Cruz Perez
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2689-6

Weitere Artikel der Ausgabe 12/2015

Supportive Care in Cancer 12/2015 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.